186 related articles for article (PubMed ID: 3025036)
1. The use of serum neutralizing antibody assay for the determination of the potency of foot and mouth disease (FMD) vaccines in cattle.
Pay TW; Hingley PJ
Dev Biol Stand; 1986; 64():153-61. PubMed ID: 3025036
[TBL] [Abstract][Full Text] [Related]
2. Selection of foot and mouth disease vaccine strains--a review.
Paton DJ; Valarcher JF; Bergmann I; Matlho OG; Zakharov VM; Palma EL; Thomson GR
Rev Sci Tech; 2005 Dec; 24(3):981-93. PubMed ID: 16642769
[TBL] [Abstract][Full Text] [Related]
3. Updating of the correlation between lpELISA titers and protection from virus challenge for the assessment of the potency of polyvalent aphtovirus vaccines in Argentina.
Maradei E; La Torre J; Robiolo B; Esteves J; Seki C; Pedemonte A; Iglesias M; D'Aloia R; Mattion N
Vaccine; 2008 Dec; 26(51):6577-86. PubMed ID: 18835312
[TBL] [Abstract][Full Text] [Related]
4. High potency vaccines induce protection against heterologous challenge with foot-and-mouth disease virus.
Brehm KE; Kumar N; Thulke HH; Haas B
Vaccine; 2008 Mar; 26(13):1681-7. PubMed ID: 18313814
[TBL] [Abstract][Full Text] [Related]
5. Reduction of animal usage in the control of foot-and-mouth disease vaccines.
Strobbe R
Dev Biol Stand; 1986; 64():163-7. PubMed ID: 3025037
[TBL] [Abstract][Full Text] [Related]
6. Effect of emergency FMD vaccine antigen payload on protection, sub-clinical infection and persistence following direct contact challenge of cattle.
Cox SJ; Voyce C; Parida S; Reid SM; Hamblin PA; Hutchings G; Paton DJ; Barnett PV
Vaccine; 2006 Apr; 24(16):3184-90. PubMed ID: 16488060
[TBL] [Abstract][Full Text] [Related]
7. [Testing the activity of anti-foot-and-mouth disease vaccine in cattle: quantitative methods of antigenic extinction].
Terré J; Stellmann C; Brun A; Favre H; Fontaine J
Dev Biol Stand; 1976; 35():357-67. PubMed ID: 198306
[TBL] [Abstract][Full Text] [Related]
8. [The effectiveness of foot-and-mouth disease vaccines in Switzerland. I. Screening tests and herd immunity].
Müller HK; Villinger F; Griot C; Ackermann M; Bruckner L; Kihm U
Schweiz Arch Tierheilkd; 1989; 131(7):379-86. PubMed ID: 2552579
[TBL] [Abstract][Full Text] [Related]
9. [Testing the effectiveness of foot-and-mouth disease vaccines: the relationship between test infection results and corresponding neutralization titers of vaccinated cattle].
Bengelsdorff HJ
Berl Munch Tierarztl Wochenschr; 1989 Jun; 102(6):193-8. PubMed ID: 2548473
[TBL] [Abstract][Full Text] [Related]
10. [The effectiveness of foot-and-mouth disease vaccines in Switzerland. II. Stability problems].
Ackermann M; Müller HK; Bruckner L; Kihm U
Schweiz Arch Tierheilkd; 1989; 131(7):389-95. PubMed ID: 2552580
[TBL] [Abstract][Full Text] [Related]
11. [Seasonal variations in the formation of virus-neutralizing antibodies in cattle after vaccination against foot-and-mouth disease].
Felfe P; Thalmann G; Kreienbrink G; Schiele K
Arch Exp Veterinarmed; 1990; 44(2):199-204. PubMed ID: 2167046
[TBL] [Abstract][Full Text] [Related]
12. An evalutation of some methods of assay of foot-and-mouth disease antigen for vaccines.
Garland AJ; Mowat GN; Fletton B
Dev Biol Stand; 1976; 35():323-32. PubMed ID: 198302
[TBL] [Abstract][Full Text] [Related]
13. Correlation of 140S antigen dose with the serum neutralizing antibody response and the level of protection induced in cattle by foot-and-mouth disease vaccines.
Pay TW; Hingley PJ
Vaccine; 1987 Mar; 5(1):60-4. PubMed ID: 3033928
[TBL] [Abstract][Full Text] [Related]
14. Foot-and-mouth disease vaccine potency testing in cattle using homologous and heterologous challenge strains: precision of the "Protection against Podal Generalisation" test.
Goris N; Maradei E; D'Aloia R; Fondevila N; Mattion N; Perez A; Smitsaart E; Nauwynck HJ; La Torre J; Palma E; De Clercq K
Vaccine; 2008 Jun; 26(27-28):3432-7. PubMed ID: 18499310
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a live-attenuated foot-and-mouth disease virus as a vaccine candidate.
Mason PW; Piccone ME; Mckenna TS; Chinsangaram J; Grubman MJ
Virology; 1997 Jan; 227(1):96-102. PubMed ID: 9007062
[TBL] [Abstract][Full Text] [Related]
16. [Studies on the suitability of tissue culture neutralization tests in the government etesting of adsorbed foot-and mouth disease vaccines. 1. The content of neutralizing antibody in the serum of cattle after vaccination with adsorbed vaccine against type O2 virus in comparison with the direct immunity testing in cattle].
Rüting E; Seils H; Weyhe D; Benndorf E
Arch Exp Veterinarmed; 1969; 23(4):827-38. PubMed ID: 4319494
[No Abstract] [Full Text] [Related]
17. The biological relevance of virus neutralisation sites for virulence and vaccine protection in the guinea pig model of foot-and-mouth disease.
Dunn CS; Samuel AR; Pullen LA; Anderson J
Virology; 1998 Jul; 247(1):51-61. PubMed ID: 9683571
[TBL] [Abstract][Full Text] [Related]
18. Antigen and vaccine banks: technical requirements and the role of the european antigen bank in emergency foot and mouth disease vaccination.
Lombard M; Füssel AE
Rev Sci Tech; 2007 Apr; 26(1):117-34. PubMed ID: 17633297
[TBL] [Abstract][Full Text] [Related]
19. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
Grubman MJ
Biologicals; 2005 Dec; 33(4):227-34. PubMed ID: 16289996
[TBL] [Abstract][Full Text] [Related]
20. Residual foot-and-mouth disease virus antibodies in French cattle and sheep six years after the vaccination ban.
Remond M; Kaiser C; Lebreton FO; Moutou F; Crucière C
Vet Res; 2001; 32(1):81-6. PubMed ID: 11254180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
